期刊
ORAL ONCOLOGY
卷 42, 期 4, 页码 415-420出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.oraloncology.2005.09.009
关键词
ameloblastomas; AM-1; OPG; RANKL; TRAIL; apoptosis
Osteoprotegerin (OPG) is a useful receptor in inhibiting Receptor Activator of NFKB Ligand (RANKL) in inducing osteoctastogenesis. Tumor Necrosis Factor (TNF)-Retated Apoptosis-Inducing Ligand (TRAIL) is a potent apoptosis-inducing ligand in amelobtastomas. Since OPG has been reported to bind to TRAIL as well, the effect of OPG in TRAIL's function in inducing apoptosis should also be investigated. To investigate on the expression of OPG in ameloblastomas, immuhistochemistry, immunofluorescence and Western blot were performed. From the immunohistochemistry results, we found that OPG was expressed in amelobtastoma tissues. Expression of OPG was clearly seen in AM-1 cells by immunofluorescence as well. Additionally, Western blot analysis confirmed OPG expression in ametoblastoma tissues and AM-1 cells. To investigate on the potential of TNF alpha, TRAIL and RANKL in inducing apoptosis, we performed an apoptosis assay. From the apoptosis assay, we found that TRAIL had the highest potential in inducing apoptosis compared to TNF alpha and RANKL. To investigate the binding of OPG with RANKL and TRAIL, we performed a binding assay. We noticed that OPG preferably bind with RANKL than TRAIL. However, at tow levels of RANKL, marked binding of OPG with TRAIL was seen. As we suspected that the binding of OPG and TRAIL might cause the effect of TRAIL in inducing apoptosis in amelobtastomas, we combined the treatment of OPG and TRAIL in AM-1 cells. From the apoptosis assay, we found that under treatment of OPG, TRAIL's function in inducing apoptosis was suppressed. These data suggest that by binding with TRAIL, OPG suppressed TRAIL's function in inducing apoptosis in ameloblastomas. (c) 2005 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据